Chemours Company Faces Securities Class Action Over Opteon Demand Claims
2 days ago
Chemours Company faces a securities class action lawsuit alleging misleading statements regarding Opteon aftermarket demand by executives. Eligible investors purchasing shares during the specified period may seek compensation.
Show all 32 updates